M Ventures β 2024 Investments
3 investments dated 2024 Β· listed companies and verified rows first Β· show all
Abselion develops measurement tools and a platform combining hardware, purpose-built assay formats, and software for biological measurements such as protein quantification.
BiotechDeep TechHardwareMedical DevicesCambridge, GB
Dr Ruizhi Wang(CEO)
Co-investorsCambridge Angels groupR42
iOnctura is a clinical-stage drug development company developing precision oral small-molecule therapies targeting the tumor-stroma-immune interface, with a pipeline including roginolisib and cambritaxestat in cancers such as uveal melanoma and pancreatic cancer.
BiotechDeep TechHealthtechMedical Devices
Catherine Pickering(Co-Founder & CEO)inLars van der Veen(Co-Founder & CSO)inMichael Lahn(CMO)inElizabeth Holt(CBO)inSteven Sciuto(CFO)inMichelle Tsai(COO)in
Co-investorsInkef3B Future Health FundVI PartnersXGEN Venture
IonKraft, a spin-off from the Institute of Plastics Processing (IKV) at RWTH Aachen University, develops a barrier coating technology for mono-material plastic containers that provides the barrier and chemical resistance of multi-layer packaging while remaining fully recyclable.
Advanced ManufacturingCircular EconomyCleantechNew MaterialsAachen, DE
Bene(Co-Founder & Managing Director)inMonty(Co-Founder & Managing Director)
Co-investorsTechVision FondsTechVision Fund
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.